A Case Series Study of Negative Pressure Platform Wound Device
NCT ID: NCT04080011
Last Updated: 2021-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2019-08-30
2019-12-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Negative Pressure Wound Therapy to Prevent Wound Complications Following Cesarean Section in High Risk Patients
NCT03082664
Incisional Negative Pressure Wound Therapy
NCT01759381
Wound Vac Polypropylene Suture Pilot Study
NCT02929238
Postoperative Pain and Skin Closure Methods After Cesarean Section
NCT02028000
NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies
NCT04955730
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NP-PWD application
All patients enrolled into the study will have the negative pressure- platform wound device applied to their surgical incision.
NP-PWD
Application of NP-PWD device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NP-PWD
Application of NP-PWD device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Scheduled for surgical intervention in which an incision will be made and skin closure will be performed.
Exclusion Criteria
2. Inability to give informed consent
3. Active malignant disease or subject is less than one year disease-free
4. Use of immunosuppressive agents, radiation or chemotherapy within the past 30 days
5. Any concomitant medications or co-morbidities that, in the opinion of the investigator, may interfere with wound healing
6. On any investigational drug(s) or therapeutic device(s) in the last 30 days or any previous enrollment in this study
7. Pregnant at enrollment
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Metis Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northeast Baptist
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NP-PWD 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.